Agber Ifan

Agber Ifan is the Director of Global Technology Services at Pfizer, bringing over twenty-three years of pharmaceutical industry experience across three major companies: Schering Plough (Merck), CIBA-Geigy (Novartis), and Pfizer. They hold a Ph.D. in Pharmaceutics from the University of Wisconsin-Madison, where they also received the Rhennebhom award for teaching excellence. Agber has demonstrated leadership in project management, regulatory compliance, and risk assessment, notably resolving the FDA consent decree for Dilantin during their tenure at Pfizer. They are a certified six sigma green belt with expertise in pre-formulation and drug product validation.